Sanofi India Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Rodolfo Hrosz

Chief executive officer

₹36.4m

Total compensation

CEO salary percentage62.5%
CEO tenure2.6yrs
CEO ownershipn/a
Management average tenure1.3yrs
Board average tenure3.9yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Rodolfo Hrosz's remuneration changed compared to Sanofi India's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

₹5b

Jun 30 2024n/an/a

₹5b

Mar 31 2024n/an/a

₹5b

Dec 31 2023₹36m₹23m

₹6b

Sep 30 2023n/an/a

₹6b

Jun 30 2023n/an/a

₹6b

Mar 31 2023n/an/a

₹6b

Dec 31 2022₹18m₹13m

₹6b

Compensation vs Market: Rodolfo's total compensation ($USD424.42K) is about average for companies of similar size in the Indian market ($USD478.11K).

Compensation vs Earnings: Rodolfo's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.


CEO

Rodolfo Hrosz (57 yo)

2.6yrs

Tenure

₹36,390,000

Compensation

Mr. Rodolfo Hrosz serves as Managing Director and Director for Sanofi India Limited since June 1, 2022. He joined Sanofi as General Manager of the Consumer Healthcare business in Brazil in 2017 and has suc...


Leadership Team

NamePositionTenureCompensationOwnership
Rodolfo Hrosz
MD & Director2.6yrs₹36.39mno data
Rachid Ayari
CFO & Whole Time Director1.1yrs₹1.51mno data
Renee Amonkar
Additional Whole Time Director1.3yrs₹1.85mno data
M. Narayanaswamy
Senior Director of Accounting & Taxation40.9yrsno datano data
Flovie Martins
Head of Corporate Communications & Corporate Social Responsibilityless than a yearno datano data
Surabhi Kaur
People & Culture Director1.3yrsno datano data
Sanjay Chavan
Head of Country Procurement - India11yrsno datano data
Nakul Verma
Senior Director of Public Affairsno datano datano data
Yasmin Shenoy
Senior Director of Regulatory Affairsno datano datano data
N. Babu
Sales & Customer Engagement Head - Diabetes and Senior Director of Diabetesno datano datano data

1.3yrs

Average Tenure

62yo

Average Age

Experienced Management: 500674's management team is not considered experienced ( 1.3 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Rodolfo Hrosz
MD & Director2.6yrs₹36.39mno data
Rachid Ayari
CFO & Whole Time Director1.1yrs₹1.51mno data
Renee Amonkar
Additional Whole Time Director1.3yrs₹1.85mno data
Usha Thorat
Independent Non-Executive Director8.8yrs₹2.68mno data
Rahul Bhatnagar
Independent Director4.5yrs₹3.04mno data
Aditya Narayan
Independent Non-Executive Chairman8.8yrs₹3.54mno data
Vaibhav Karandikar
Non-Executive Director3.9yrs₹20.23mno data

3.9yrs

Average Tenure

66yo

Average Age

Experienced Board: 500674's board of directors are considered experienced (3.9 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/02 06:25
End of Day Share Price 2025/01/02 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Sanofi India Limited is covered by 14 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Sarabjit NangraAngel Broking Private Limited
Rohit BhatBatlivala & Karani Securities India Pvt. Ltd.
Ranjit KapadiaCentrum Broking Limited